Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
2022 Global Forecast for Cell Viability Assays (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Global Rat and Mouse Model Market Size study, by Type (Knockout, Knock-in, Outbred, Inbred, Others), By Technology (Nuclear transferase, Microinjection, Embryonic stem cells, CRISPR/Cas9, Others) By Service (Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending, Others), By Application (Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies, Others), By End-use (Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) and Regional Forecasts 2021-2027
... By Application (Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies, Others), By End-use (Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) and Regional Forecasts 2021-2027 Global Rat and ... Read More
-
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
CAR T-cell Therapy - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage CAR ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin"s lymphoma (NHL) - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Allogenic iNKT cell therapy - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Allogenic iNKT cell ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Limbal ... Read More
-
CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Region: Segment Forecast, 2022 – 2029
... Lymphoma (FL), Others); By Region: Segment Forecast, 2022 – 2029 The global CAR-T cell therapy market size is expected to reach USD 20,566.5 million by 2029 according to a new study published by Polaris Market ... Read More
-
Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Hematopoietic Stem Cell ... Read More
-
Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026
... Cell Therapy And Neuromodulation Surgery), By Product (Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors], Neuromodulation Devices [External Neuromodulation Devices {Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices}, Internal Neuromodulation Devices {Spinal Cord ... Read More
-
Cell Proliferation Kit Market Segmentation by Method (Colorimetry, Fluorescence, and Others); and by Application (Clinical, Industrial & Applied Science, and Stem Cell Research) – Global Demand Analysis & Opportunity Outlook 2030
... has released a report titled Cell Proliferation Kit Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According to a study by Fatpos Global, is anticipated to ... Read More
-
CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 CD19/CD20 Bi-specific CAR-T Understanding The ... Read More
-
Stem Cell Mobilization - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Stem Cell Mobilization Understanding The ... Read More
-
Stem Cell Therapy Market- By Cell Source (Adipose Tissue-Derived Mesenchymal SCs, Bone Marrow-Derived Mesenchymal SCs, And Embryonic SCs), By Type (Allogenic SCs And Autologous SCs), By End-User (ASCs And Hospitals), And By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, And Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2030
... Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, And Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2030 Market Overview Fatpos Global has released a report titled Stem Cell Therapy Market - Analysis ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast - 2032
... epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) ... Read More
-
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
... (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for ... Read More
-
Global Regenerative Medicine Market Analysis & Forecast to 2025; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries
... (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $35 billion in ... Read More
-
Global Cell Therapy - Market and Technology Forecast to 2028
... ones through the process of injection/ grafting or implantation. Cell therapy is done to effectuate a medicinal effect, i.e. for the very instance, Cancer cells are substituted by T-cells to initiate cell-mediated immunity in the ... Read More
-
Cell Therapy and Gene Therapy Markets
... products. Cell and gene therapy products are transforming the treatment of cancers and genetic diseases, as well as expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases, and many ... Read More
-
CAR-T Cell Therapy Market Review
... that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a ... Read More
Research Assistance
